Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis
- PMID: 25783764
- DOI: 10.1002/hep.27790
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis
Abstract
Hepatocellular carcinoma (HCC) develops through a multistage process, but the nature of the molecular changes associated with the different steps, the very early ones in particular, is largely unknown. Recently, dysregulation of the NRF2/KEAP1 pathway and mutations of these genes have been observed in experimental and human tumors, suggesting their possible role in cancer development. To assess whether Nrf2/Keap1 mutations are early or late events in HCC development, we investigated their frequency in the rat Resistant Hepatocyte model, consisting of the administration of diethylnitrosamine followed by a brief exposure to 2-acetylaminofluorene. This model enables the dissection of all stages of hepatocarcinogenesis. We found that Nrf2/Keap1 mutations were present in 71% of early preneoplastic lesions and in 78.6% and 59.3% of early and advanced HCCs, respectively. Mutations of Nrf2 were more frequent, missense, and located in the Nrf2-Keap1 binding region. Mutations of Keap1 occurred at a much lower frequency in both preneoplastic lesions and HCCs and were mutually exclusive with those of Nrf2. Functional in vitro and in vivo studies showed that Nrf2 silencing inhibited the ability of tumorigenic rat cells to grow in soft agar and to form tumors. Unlike Nrf2 mutations, those of Ctnnb1, which are frequent in human HCC, were a later event as they appeared only in fully advanced HCCs (18.5%).
Conclusion: In the Resistant Hepatocyte model of hepatocarcinogenesis the onset of Nrf2 mutations is a very early event, likely essential for the clonal expansion of preneoplastic hepatocytes to HCC, while Ctnnb1 mutations occur only at very late stages. Moreover, functional experiments demonstrate that Nrf2 is an oncogene critical for HCC progression and development.
© 2015 by the American Association for the Study of Liver Diseases.
Comment in
-
NRF2/KEAP1 and Wnt/β-catenin in the multistep process of liver carcinogenesis in humans and rats.Hepatology. 2015 Sep;62(3):677-9. doi: 10.1002/hep.27828. Epub 2015 Jun 9. Hepatology. 2015. PMID: 25846427 No abstract available.
Similar articles
-
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis.J Hepatol. 2018 Sep;69(3):635-643. doi: 10.1016/j.jhep.2018.05.010. Epub 2018 Jun 22. J Hepatol. 2018. PMID: 29758334
-
Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.Hepatology. 2021 Aug;74(2):741-759. doi: 10.1002/hep.31730. Epub 2021 Jun 21. Hepatology. 2021. PMID: 33529367 Free PMC article.
-
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.Cell Mol Gastroenterol Hepatol. 2022;13(1):113-127. doi: 10.1016/j.jcmgh.2021.08.011. Epub 2021 Sep 14. Cell Mol Gastroenterol Hepatol. 2022. PMID: 34530178 Free PMC article.
-
Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.Int J Mol Sci. 2020 Jul 29;21(15):5378. doi: 10.3390/ijms21155378. Int J Mol Sci. 2020. PMID: 32751080 Free PMC article. Review.
-
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317. World J Gastroenterol. 2015. PMID: 26034368 Free PMC article. Review.
Cited by
-
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma.Front Oncol. 2022 Sep 20;12:941552. doi: 10.3389/fonc.2022.941552. eCollection 2022. Front Oncol. 2022. PMID: 36203462 Free PMC article.
-
Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.Oncotarget. 2016 Oct 4;7(40):65389-65402. doi: 10.18632/oncotarget.11700. Oncotarget. 2016. PMID: 27588483 Free PMC article.
-
Anticancer therapeutic effect of ginsenosides through mediating reactive oxygen species.Front Pharmacol. 2023 Jul 26;14:1215020. doi: 10.3389/fphar.2023.1215020. eCollection 2023. Front Pharmacol. 2023. PMID: 37564184 Free PMC article. Review.
-
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis.Oncotarget. 2017 Feb 28;8(9):15716-15731. doi: 10.18632/oncotarget.14984. Oncotarget. 2017. PMID: 28157710 Free PMC article.
-
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.J Clin Invest. 2017 May 1;127(5):1856-1872. doi: 10.1172/JCI90253. Epub 2017 Apr 10. J Clin Invest. 2017. PMID: 28394261 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous